---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-215654"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2026-05-11T23:59:59+00:00"
generated_at: "2026-05-14T19:20:36.586286+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Accendra Health launches $326.25M 9% first lien notes, $300M revolver, and exchange offers for existing notes

## Summary
- New $326.25M 9.000% Senior Secured First Lien Notes due 2032 and $300M revolver due 2030.
- Exchange offers for all 4.500% 2029 Notes and 83% of 6.625% 2030 Notes; backstop parties commit to purchase up to $261M of new notes.
- Consent solicitations to eliminate most covenants and modify defaults; new 9.750% Second Lien Notes due 2033 also offered.
- Transactions expected to close by June 30, 2026; proceeds used to repay existing term loan A and revolver borrowings.

## SEC filing metadata
- accession: 0001193125-26-215654
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2026-05-11T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000119312526215654/0001193125-26-215654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000119312526215654/d135857d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-215654
- JSON: https://secwatch.observer/filing/0001193125-26-215654.json
- Plain text: https://secwatch.observer/filing/0001193125-26-215654.txt

## Source-grounded claims
- claim_id: ca3fc50bfb71e97efc7aedd2ca58bb5277f7a09a
  claim: ACCENDRA HEALTH INC/VA/ entered into Commitment and Consent Letter with certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement (effective 2026-05-11).
  evidence_excerpt: On May 11, 2026, Accendra Health, Inc. (the “ Company ”) entered into a Commitment and Consent Letter (the “ Commitment Letter ”) with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 (the “ 2029 Notes ”) and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding approximately all of the outstanding principal amount of the 2029 Notes and approximately 83% of the outstanding principal amount of the 2030 Notes as of May 11, 2026 and (ii) lenders under the Company’s existing Term Loan Credit Agreement (as defined below) (collectively, the “ Commitment and Consenting Parties ” and each, a “ Commitment and Consenting Party ”), (b) certain lenders under the Company’s existing Term Loan Credit Agreement consenting solely with respect to the Term B-1 Term Loan Consent (as defined below) (the “ Term B-1 Term Loan Consenting Parties ”) and (c) all lenders under the Company’s Exist
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312526215654/0001193125-26-215654-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.